Ettinger, B. et al., "Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures," Ann. Int. Med. 102:319-324 (1985). |
Ettinger, B. et al., "Postmenopausal Bone Loss is Prevented by Treatment with Low-Dosage Estrogen with Calcium," Ann. Int. Med. 106:40-45 (1987). |
Ettinger, B. et al., "Low-dosage micronized 17.beta.-estradiol prevents bone loss in postmenopausal women," Am. J. Obst. Gyn. 166(2):479-488 (1992). |
Evans, S.F. et al., "Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all postmenopausal ages," Clin. Endo. 44:79-84 (1996). |
Hillard, T.C. et al., "Long-Term Effects of Transdermal and Oral Hormone Replacement Therapy on Postmenopausal Bone Loss," Osteoporosis Int. 4:341-348 (1994). |
Horsman, A. et al., "The Effect of Estrogen Dose on Postmenopausal Bone Loss," N. Engl. J. Med. 309(23):1405-1407 (1983). |
Lindsay, R. et al., "The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss," Obst. Gyn. 63(6):759-763 (1984). |
Naessen, T. et al., "Bone loss in elderly women prevented by ultralow doses of parental 17.beta.-estradiol," Am. J. Obst. Gyn. 177(1):115-119 (1997). |
Stevenson, J.C. et al., "Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women," The Lancet 336:265-269 (1990). |
Tepper, R. et al., "Estrogen Replacement in Postmenopausal Women: Are We Currently Overdosing Our Patients," Gyn. Obst. Invest. 38:113-116 (1994). |